Psychopharmacological treatment before suicide attempt among patients admitted to a Psychiatric Intensive Care Unit

Journal of Affective Disorders

Volumn 113, Issue 1-2, 2009, Pages 37-44

  Raja, Michele ^a   Azzoni, Antonella ^a   Koukopoulos, Alexia E ^b  

^a SPIRITO SANTO HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Antidepressants; Bipolar Disorder; Major Depression; Suicide; Treatment

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT;

ADULT; ANXIETY DISORDER; ARTICLE; BIPOLAR DEPRESSION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DRUG USE; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; MENTAL HEALTH CENTER; MOOD DISORDER; OPEN STUDY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SCHIZOAFFECTIVE PSYCHOSIS; SUICIDE ATTEMPT;

ADULT; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; BRIEF PSYCHIATRIC RATING SCALE; DEPRESSIVE DISORDER, MAJOR; EMERGENCY SERVICES, PSYCHIATRIC; FEMALE; HOSPITALIZATION; HUMANS; INTENSIVE CARE UNITS; MALE; PSYCHOPHARMACOLOGY; PSYCHOTIC DISORDERS; SEVERITY OF ILLNESS INDEX; SUICIDE, ATTEMPTED;

EID: 58149167032     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2008.04.024     Document Type: Article

References (25)

1. Akiskal H.S., and Benazzi F. The DSM-IV and ICD-10 categories of recurrent [major] depressive and bipolar II disorders: evidence that they lie on a dimensional spectrum. J. Affect. Disord. 92 (2006) 45-54
2. Akiskal H.S., Benazzi F., Perugi G., and Rihmer Z. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy. J. Affect. Disord. 85 (2005) 245-258
3. Angst J., and Cassano G. The mood spectrum: improving the diagnosis of bipolar disorder. Bipolar Disord. 7 suppl. 4 (2005) 4-12
4. Baldessarini R.J., Tondo L., Strombom I.M., Dominguez S., Fawcett J., Licinio J., Oquendo M.A., Tollefson G.D., Valuck R.J., and Tohen M. Ecological studies of antidepressant treatment and suicidal risks. Harv. Rev. Psychiatry 15 (2007) 133-145
5. Bauer M.S., Simon G.E., Ludman E., and Unu{double acute}tzer J. 'Bipolarity' in bipolar disorder: distribution of manic and depressive symptoms in a treated population. Br. J. Psychiatry 187 (2005) 87-88
6. Culpepper L., Davidson J.R., Dietrich A.J., Goodman W.K., Kroenke K., and Schwenk T.L. Suicidality as a possible side effect of antidepressant treatment. J. Clin. Psychiatry 65 (2004) 742-749
7. Fergusson D., Doucete S., Cranley Glass K.C., Shapiro S., Healy D., Hebert P., and Hutton B. Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomized controlled trials. BMJ 330 (2005) 396-399
8. Friedman R.A., and Leon A.C. Expanding the black box - depression, antidepressants, and the risk of suicide. N. Engl. J. 356 (2007) 2343-2346
9. Gibbons R.D., Brown C.H., Hur K., Marcus S.M., Bhaumik D.K., and Mann J.J. Relationship between antidepressants and suicide attempts: an analysis of the Veterans Health Administration data sets. Am. J. Psychiatry 164 (2007) 989-991
10. Gunnell D., Saperia J., and Ashby D. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomized controlled trials submitted to the MHRA's safety review. BMJ 330 (2005) 385-388
11. Hantouche E.G., and Akiskal H.S. Bipolar II vs. unipolar depression: psychopathologic differentiation by dimensional measures. J. Affect. Disord. 84 (2005) 127-132
12. Healy D., and Whitaker C. Antidepressants and suicide: risk benefits conundrum. J. Psychiatry Neurosci. 28 (2003) 331-337
13. Jallade C., Sarfati Y., and Hardy-Bayle M.C. Clinical evolution after self-induced or accidental traumatism: a controlled study of the extent and the specificity of suicidal catharsis. J. Affect. Disord. 85 (2005) 283-292
14. Jick H., Kaye J.A., and Jick S.S. Antidepressants and the risk of suicidal behaviors. JAMA 292 (2004) 338-343
15. Khan A., Khan S., Kolts R., and Brown W.A. Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports. Am. J. Psychiatry 160 (2003) 790-792
16. Koukopoulos A., and Koukopoulos Al. Agitated depression as a mixed state and the problem of melancholia. Psychiatr. Clin. North Am. 22 (1999) 547-564
17. Koukopoulos A., Albert M.J., Sani G., Koukopoulos A.E., and Girardi P. Mixed depressive states: nosologic and therapeutic issues. Int. Rev. Psychiatry 17 (2005) 21-37
18. Morrison E.F. A hierarchy of aggressive and violent behaviors among psychiatric inpatients. Hosp. Commun. Psychiatry 43 (1992) 505-506
19. Moscicki E.K. Identification of suicide risk factors using epidemiologic studies. Psychiatr. Clin. North Am. 20 (1997) 499-517
20. Perugi G., Akiskal H.S., Micheli C., Toni C., and Madaro D. Clinical characterization of depressive mixed state in bipolar-I patients: Pisa-San Diego collaboration. J. Affect. Disord. 67 (2001) 105-114
21. Rihmer Z. Suicide risk in mood disorders. Curr. Opin. Psychiatry 20 (2007) 17-22
22. Rihmer Z., and Akiskal H.S. Do antidepressants t(h)reat(en) depressives? Toward a clinically judicious formulation of the antidepressant-suicidality FDA advisory in light of declining national suicide statistics from many countries. J. Affect. Disord. 94 (2006) 3-13
23. Suppes T., Kelly D.I., and Perla J.M. Challenges in the management of bipolar depression. J. Clin. Psychiatry 66 Suppl 5 (2005) 11-16
24. Tiihonen J., Lönnqvist J., Wahlbeck K., Klaukka T., Tansanen A., and Haukka J. Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort. Arch. Gen. Psychiatry 63 (2006) 1358-1367
25. Zetin M., and Hoepner C.T. Relevance of exclusion criteria in antidepressant clinical trials: a replication study. J. Clin. Psychopharmacol. 27 (2007) 295-301